Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Omollo

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Plos Neglected Tropical Diseases|November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trialAsrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Lancet (London, England)|March 16, 2020
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trialRichard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, et al.
Plos Neglected Tropical Diseases|June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trialAhmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Plos Neglected Tropical Diseases|November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trialAsrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Lancet (London, England)|March 16, 2020
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trialRichard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, et al.
Plos Neglected Tropical Diseases|June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trialAhmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Pageof 3